In the realm of advanced organic synthesis, specific chemical intermediates serve as the bedrock for creating complex and therapeutically vital molecules. 2-Cyclopropyl-4-(4-fluorophenyl)quinoline-3-carbaldehyde (CAS: 121660-37-5) stands out as such a compound, primarily recognized for its indispensable role in the synthesis of Pitavastatin Calcium. This article delves into the chemical nature, synthesis considerations, and the diverse applications of this quinoline derivative, offering insights for R&D scientists and product formulators.

Chemical Profile and Properties

2-Cyclopropyl-4-(4-fluorophenyl)quinoline-3-carbaldehyde is characterized by its quinoline core, featuring a cyclopropyl group at the 2-position, a 4-fluorophenyl group at the 4-position, and a carbaldehyde (aldehyde) group at the 3-position. Its molecular formula is C19H14FNO, with a molecular weight of approximately 291.32 g/mol. Typically appearing as an off-white to slight yellow crystalline powder, its physical properties, such as melting point and solubility, are critical for its handling and reactivity in subsequent synthetic steps. Its precise specifications, including a minimum assay of 98.0% and a low loss on drying (≤1.0%), underscore its suitability for demanding pharmaceutical applications. When you buy this chemical, understanding these properties aids in optimizing reaction conditions.

Synthesis Pathways and Considerations

The synthesis of 2-Cyclopropyl-4-(4-fluorophenyl)quinoline-3-carbaldehyde involves intricate multi-step organic reactions. While specific proprietary synthesis routes vary among manufacturers, they generally aim to efficiently construct the quinoline ring system and introduce the requisite substituents. Common strategies might involve cyclization reactions and functional group transformations. For chemists seeking to buy this compound, knowledge of its synthesis can provide context for its quality and cost. Manufacturers often focus on optimizing yields, minimizing impurities, and ensuring scalability to meet market demand. Sourcing this intermediate from reliable suppliers ensures that these complex synthesis challenges have been successfully navigated.

Key Applications in Pharmaceutical Development

The predominant application of 2-Cyclopropyl-4-(4-fluorophenyl)quinoline-3-carbaldehyde is its use as a crucial intermediate in the synthesis of Pitavastatin Calcium. This statin is a potent inhibitor of HMG-CoA reductase, an enzyme essential for cholesterol biosynthesis in the liver, making it a cornerstone in the treatment of hyperlipidemia and the prevention of cardiovascular diseases. The aldehyde functionality of the intermediate is strategically utilized to extend the carbon chain and incorporate the necessary stereochemistry for the final active pharmaceutical ingredient (API). Its specific structure contributes directly to the pharmacological activity of Pitavastatin Calcium.

For researchers and formulators, purchasing this intermediate from reputable manufacturers, often available at competitive prices from suppliers in China, is key to advancing drug discovery and development pipelines. Its availability as a catalog chemical simplifies the R&D process, allowing scientists to focus on the downstream synthesis and formulation without the burden of its initial production.